| Literature DB >> 20541386 |
Damian Palafox1, Luis Llorente, Josefina Alberú, Adriana Torres-Machorro, Nancy Camorlinga, Cinthya Rodríguez, Julio Granados.
Abstract
The aim of this review is to present current information on transplantation research regarding the role of indoleamine 2,3 dioxygenase in immune regulation. We present the basic mechanisms by which the enzyme is expressed, followed by tryptophan catabolism that leads to midg1 phase arrest and apoptosis. Other effects proposed, although not yet completely proven and generally accepted, include T-cell development suppression, secretion of regulatory cytokines such as IL10, and generation of new T regulatory cells. Clinical studies are being performed worldwide; thus, our goal is to focus on the clinical potential relevance of the enzyme rather than a presentation on a molecular basis so that health care providers concerning transplantation are aware of this promising field in immunology and therapeutics. We do emphasize the fact that information regarding the role of indoleamine 2,3 dioxygenase in human beings is still scarce. Copyright 2010 Elsevier Inc. All rights reserved.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20541386 DOI： 10.1016/j.trre.2010.04.003
Source DB: PubMed Journal: Transplant Rev (Orlando) ISSN： 0955-470X Impact factor: 3.943